je.st
news
Home
› ACADIA Pharmaceuticals Announces Advancement By Allergan Of Novel Glaucoma Compound Into Preclinical Development
ACADIA Pharmaceuticals Announces Advancement By Allergan Of Novel Glaucoma Compound Into Preclinical Development
2013-06-03 11:00:00| drugdiscoveryonline News Articles
ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that Allergan, Inc. has advanced an additional product candidate as a potential new treatment for glaucoma
Tags: development
compound
announces
pharmaceuticals
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||